Reportedly, Chi3l1 is significantly increased and a promising biomarker for multiple neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), dementia, and amyotrophic lateral sclerosis (ALS) (Figure 1). This evidence concerns the gene CHI3L1 and amyotrophic lateral sclerosis.